Chemoinformaics analysis of 2,6-DIMETHYLOCT-7-EN-3-OL
| Molecular Weight | 156.269 | nRot | 5 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 21 |
| Exact Molecular Weight | 156.151 | nRing | 0 |
| Solubility: LogS | -5.118 | nHRing | 0 |
| Solubility: LogP | 6.783 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 30.8379 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.413 |
| Synth | 4.861 |
| Natural Product Likeliness | 2.894 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.622 |
| Pgp-sub | 0 |
| HIA | 0.012 |
| CACO-2 | -4.895 |
| MDCK | 0.00000831 |
| BBB | 0.819 |
| PPB | 0.983095 |
| VDSS | 1.33 |
| FU | 0.0256603 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.49 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.968 |
| CYP2c9-inh | 0.107 |
| CYP2c9-sub | 0.423 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.875 |
| CYP3a4-inh | 0.174 |
| CYP3a4-sub | 0.588 |
| CL | 16.938 |
| T12 | 0.016 |
| hERG | 0.028 |
| Ames | 0.015 |
| ROA | 0.04 |
| SkinSen | 0.265 |
| Carcinogencity | 0.007 |
| EI | 0.036 |
| Respiratory | 0.78 |
| NR-Aromatase | 0.368 |
| Antiviral | No |
| Prediction | 0.92895 |